(Q39581594)

English

The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats

scientific article published on 4 March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

V Ashutosh Rao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jun Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sarah R Klein

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Parvaneh Espandiari

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Alan Knapton

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jennifer S Dickey

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Eugene Herman

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Emily B Shacter

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

4 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1125-1134

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-011-1587-y

0 references

Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

GammaH2AX and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Intercellular communication of cellular stress monitored by gamma-H2AX induction

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

The iron chelator Dp44mT does not protect myocytes against doxorubicin.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Doxorubicin-induced apoptosis: implications in cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Creating and curing fatty hearts

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

DNA topoisomerase II, genotoxicity, and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Megabase chromatin domains involved in DNA double-strand breaks in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Serum troponins as biomarkers of drug-induced cardiac toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1587-Y

21 January 2018

Identifiers

10.1007/S00280-011-1587-Y

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39581594&oldid=1841823647"